期刊
EPILEPTIC DISORDERS
卷 22, 期 4, 页码 511-514出版社
JOHN LIBBEY EUROTEXT LTD
DOI: 10.1684/epd.2020.1189
关键词
Epidiolex; cannabinoid; skin; rash; hypersensitivity reaction; antiepileptics; drug interaction; CBD; Epidiolex (R) (cannabidiol)
Epidiolex (R) (cannabidiol, aka CBD) is a recently approved FDA prescription drug for the treatment of epilepsy associated with Lennox-Gastaut and Dravet syndromes, and is increasingly used for treatment-resistant epilepsy. Rash was rarely reported in Epidiolex (R) clinical trial data. We report a case of Epidiolex (R)-related skin rash that developed in a delayed fashion in a 23-year-old female with medically refractory epilepsy. We also review the potential mechanism of Epidiolex (R)-related skin rash.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据